Characterization of the vaccine candidate has been undertaken at ICMR-NIV followed by safety and tolerability studies in small animals like rats, mice and rabbits. Status of clinical trials is as follows:Phase I clinical trials along with parallel studies in large animals have been completed. "The trial has revealed excellent safety of the candidate vaccine. Status of clinical trials is as follows:Phase I clinical trials have been completed. "The trial has revealed excellent safety of the candidate vaccine," he said.

Source: Mint September 15, 2020 10:38 UTC